WATERS CORP /DE/ (WAT): 8-K filed August 4, 2026

AI analysis of the 8-K that WATERS CORP /DE/ filed with the U.S. SEC on August 4, 2026, grounded in the primary-source EDGAR filing.

• Raised Full-Year 2026 Guidance Across All Metrics – Management raised organic revenue growth to 7-9%, acquired business revenue to $3.045B, and adjusted EPS to $14.45-$14.65 (10-12% growth), signaling confidence in strengthening end-market conditions and better-than-expected Q2 momentum.

• Accelerating Organic Growth with Strong Divisional Performance – Organic revenue growth reached 9% in constant currency, with ASD achieving 8% instrument growth and double-digit chemistry consumables growth; Biosciences division ahead of schedule in revitalization, now in mid-single-digit growth territory.

• GAAP EPS Temporarily Pressured by Acquisition Accounting – Q2 GAAP EPS declined to ($1.39) vs. $2.47 year-over-year due to non-cash acquisition charges (intangible amortization, inventory step-up), which will continue through integration but do not impact adjusted EPS performance.

• Management Tone: Very Optimistic – Confident outlook reflects improving operational execution, successful integration progress, and broad-based end-market demand recovery, particularly in previously underperforming customer segments.

Filing analysis — key questions

Answers are generated from this SEC filing and StockHuntr's analysis. Not investment advice.

What does WATERS CORP /DE/ (WAT)'s 8-K filed August 4, 2026 say?

Item 2.02 - Results of Operations and Financial Condition: The filing reports results of operations and financial condition for Waters Corporation as of August 4, 2026 Item 9.01 - Financial Statements and Exhibits: The filing includes financial statements and exhibits related to the reported results Company Information: Waters Corporation, a Delaware-incorporated laboratory analytical instruments…

Is WAT's 8-K bullish or bearish?

Our analysis rates this filing NEUTRAL. Waters presents a MODERATE concern profile with a NEUTRAL net assessment. The company is executing well operationally—beating quarterly guidance, raising full-year guidance across all metrics, and demonstrating strong organic growth acceleration (9% constant…

How concerning is WAT's latest 8-K?

Concern level: ELEVATED (4.2/10). Key factors: Integration Risk from Major Acquisition (Severity 6/10): ~$817M quarterly revenue from BD acquisition introduces material execution complexity; historical allocated costs may not be representative of future standalone costs, creating earnings quality uncertainty; Acquired Business Cost Allocation Uncertainty (Severity 5/10): BD's shared services…

What are the main risks flagged in WAT's 8-K?

Notable risk changes: POSITIVE: Company raised ALL components of 2026 guidance - organic revenue growth (7-9%), acquired business revenue ($3.045B), and adjusted EPS ($14.45-$14.65 representing 10-12% growth). This reflects better-than-expected Q2 results and strengthening end-market conditions across previously lagging customer segments.; POSITIVE: Organic revenue growth accelerated to 9% in constant currency (vs.…

Did WAT beat or miss expectations in this filing?

Total revenue surpassed high end of guidance range; Biosciences and Diagnostic Solutions revenue exceeded guidance by $15 million.

What is the 30-day stock outlook for WAT after this filing?

The model predicts WAT will underperform the S&P 500 by about 0.0% over 30 days. This is model analysis for research, not investment advice.

About this analysis

Primary source:
View this 8-K on SEC EDGAR
Additional data:
Yahoo Finance (market data)
Method:
StockHuntr analyzes filings with AI — see our methodology.
Analysis as of:
August 4, 2026
Published by:
StockHuntr

For research and education only. Nothing here is investment advice.

📄

Fetching Filing from SEC

Downloading filing HTML from SEC.gov...

15% Complete
1
Fetch filing from SEC
2
Parse document sections
3
Fetch prior filing
4
Analyze risk factors
5
Analyze management sentiment
6
Extract financial metrics
7
Compare to analyst consensus
8
Run ML prediction model
9
Finalize analysis

Note: Analysis typically takes 30-60 seconds. We're fetching real SEC filing data and running AI analysis on the actual content.